- $1.03m
- $31.39m
- $16.00m
Biotricity Inc expected to post a loss of 11 cents a share - Earnings Preview
Biotricity Inc expected to post a loss of 11 cents a share - Earnings Preview
Biotricity Inc reports results for the quarter ended in December - Earnings Summary
Biotricity Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Biotricity Inc - Files Prospectus Related To Public Offering Of Up To 20.4 Million Shares By Selling Stockholder
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM
Biotricity Inc reports results for the quarter ended in September - Earnings Summary
Brief: Biotricity Inc Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Biotricity Prepares 510(K) FDA Filing For Biotres
Brief: Biotricity Received Communication From FDA Stating Bioflux Software Device is in Substantiative Phase
Brief: Biotricity announces it has filed its response to FDA with additional information requested